Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-007061
Filing Date
2022-06-29
Accepted
2022-06-29 20:11:12
Documents
1
Period of Report
2022-06-27

Document Format Files

Seq Description Document Type Size
1 form4-06292022_050657.html 4  
1 form4-06292022_050657.xml 4 3608
  Complete submission text file 0001415889-22-007061.txt   5056
Mailing Address C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200 DURHAM NC 27703
Business Address
Brazzell Romulus K (Reporting) CIK: 0001298079 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 221056188

Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations